Virtual Reality Helmet to Test for Problems With Memory
NCT ID: NCT00454454
Last Updated: 2013-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
425 participants
OBSERVATIONAL
2007-03-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury
NCT06375421
Online Memory Intervention for Individuals with Traumatic Brain Injury
NCT04331392
Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)
NCT00714571
Computerized Memory Enhancing Treatment in MCI
NCT05332522
Photobiomodulation to Improve Cognition in TBI, With fMRI
NCT04230577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Comparison: virtual reality display device compared to the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No treatment
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MMSE of 18 or greater or mini-cog of 4 or greater
* Ability to read
* Informed consent given
Exclusion Criteria
* Non-English speaking
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wallace H. Coulter Foundation
OTHER
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Wright
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David W Wright, MD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wesley Woods Health Center
Atlanta, Georgia, United States
Wesley Woods Outpatient Clinic
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wright DW, Nevarez H, Kilgo P, LaPlaca M, Robinson A, Fowler S, Brumfield J, Goldstein FC. A novel technology to screen for cognitive impairment in the elderly. Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):484-91. doi: 10.1177/1533317511426133. Epub 2011 Nov 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
797-2002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.